Lipoplus

Omega-3-Acid Triglycerides, the active ingredient in Lipoplus, is an Omega-3 fatty acid lipid emulsion presented as an intravenous lipid emulsion for intravenous use. It provides essential fatty acids and calories for patients who cannot receive enteral feeding, supporting energy needs and cell membrane synthesis in critically ill, postoperative, or malnourished individuals.

GNH USA supplies Lipoplus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, including intensive care units and surgical centres, ensuring consistent quality, regulatory compliance and timely delivery.

Lipoplus, an intravenous omega‑3 fatty acid lipid emulsion, is used to address nutritional deficiencies in patients requiring parenteral support. - Parenteral nutrition for patients unable to receive enteral feeding: Provides essential fatty acids and calories to meet energy requirements. - Supplementation of essential fatty acids in critically ill or postoperative patients: Supports cell membrane integrity and reduces inflammatory stress. - Management of malnutrition in surgical or intensive care settings: Helps restore nutritional balance during prolonged fasting or catabolic states.

Lipoplus may be associated with several adverse reactions.

Common Side Effects: - Hypertriglyceridemia: Elevated serum triglyceride levels during therapy. - Fever or chills: Transient temperature rise following infusion. - Infusion site reactions: Redness, swelling, or discomfort at the catheter site. - Mild hypotension: Temporary drop in blood pressure during administration.

Serious or Rare Side Effects: - Fat overload syndrome: Severe metabolic disturbance from excess lipid load. - Anaphylactic reaction: Acute hypersensitivity requiring immediate medical intervention. - Pancreatitis: Inflammation of the pancreas linked to high triglyceride concentrations. - Hepatic dysfunction: Abnormal liver enzyme elevations in susceptible patients.

When using Lipoplus, clinicians should observe several safety measures. - Assess triglyceride levels: Monitor serum triglycerides before and during therapy. - Check for fish‑oil allergy: Avoid in patients with known hypersensitivity to omega‑3 sources. - Avoid in severe hyperlipidemia: Risk of fat overload in patients with markedly elevated lipids. - Use caution in hepatic impairment: Monitor liver function tests regularly. - Monitor for signs of infection: Observe catheter site for redness or discharge. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Lipoplus can interact with other medications and therapies.

Major Interactions (Avoid): - Concomitant lipid emulsions: Increases risk of fat overload syndrome. - High‑dose propofol infusion: Adds to total lipid load, potentially causing hypertriglyceridemia. - Cytotoxic chemotherapy agents: May alter lipid metabolism and increase toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): Possible effect on INR and bleeding risk. - Statins: May raise the likelihood of myopathy when combined with elevated triglycerides. - Beta‑agonists: Can influence triglyceride metabolism, requiring periodic lipid monitoring.